Experimental eye drug hopes to slow inherited blindness
NCT ID NCT06970106
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 26 times
Summary
This study tests a new medicine called PYC-001, given as an injection into the eye, for people with a rare genetic condition (OPA1 mutation) that causes vision loss. The main goal is to check safety and find the best dose. About 18 adults will receive either one dose or three doses over several weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPA1 GENE MUTATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cerulea Clinical Trials
RECRUITINGEast Melbourne, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Retina Specialists
RECRUITINGAuckland, 1052, New Zealand
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Save Sight Institute - Sydney Eye Hospital
RECRUITINGSydney, New South Wales, 2000, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.